Economists and institutions have cut their forecasts and experts are predicting the potential onset of recessionary environments.

Global companies are also concerned about the rising risk of Covid-19, with thousands of the world’s leading companies explicitly mentioning its impact on their business in their latest company filings.


The IMF estimates growth of -4.7% for the Middle East and Central Asian region.


Goldman Sachs expects UK unemployment to rise to 9.5% by December 2020 because its job retention scheme ends in October.

Maximum, Minimum and Mean of all new GDP growth estimates by week​​​​​​​


As of 29 July 2020

CardiovASCULAR Devices

Among the cardiovascular markets, pacemakers have been particularly hit by the pandemic. GlobalData estimates the US market for pacemaker devices was worth $782m in 2019, but as a result of Covid-19, the 2020 market value has been cut by around 50% of previous estimates for 2020, to $400m, with the market not recovering to a status resembling pre-Covid-19 until 2022.


The Spinal Fusion market is expected to contract by 15.7% in 2020, and slowly recover during 2021.

General Surgery Devices


In the US,  more than 29 states have allowed the resumption of general surgeries but under strict guidelines to prevent further Covid-19 infection. 

Key mediCal market developments

Share this article